About: Review: An insight into coronaviruses: Challenges, security and scope

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Review: An insight into coronaviruses: Challenges, security and scope Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Review: An insight into coronaviruses: Challenges, security and scope
Creator	Gupta, K Davariya, Vipul Gajjar, P Lancelot D'cruz, \| Pankaj Gajjar, \| Parmar, Jitendra Sanjeev, \| Shah, Niyati
source	Medline; PMC
abstract	SARS‐CoV2 is a novel coronavirus; the seventh of its species to infect humans. The spread of this virus emerged in Wuhan, China in late December, 2019. Since then, this virus has spread to more than 200 countries and has caused a worldwide pandemic. Being a new species of coronaviruses, any cure or vaccines for this virus has not yet been obtained. A large amount of scientific studies and clinical trials are being carried out across the world to find a potential vaccine for this virus. Current work reports a review of potential drugs and vaccines that may be effective against this virus. Different scientific therapies that may potentially be effective against the SARS‐CoV2 virus are also reviewed. The mechanisms of various drugs, their efficiency in various clinical trials and their side effects are also studied.
has issue date	2020-08-04(xsd:dateTime)
bibo:doi	10.1002/rmv.2138
bibo:pmid	32754974
has license	no-cc
sha1sum (hex)	a6f3415e7a9286882435641655b8417634290b8a
schema:url	https://doi.org/10.1002/rmv.2138
resource representing a document's title	Review: An insight into coronaviruses: Challenges, security and scope
has PubMed Central identifier	PMC7435549
has PubMed identifier	32754974
schema:publication	Rev Med Virol
resource representing a document's body	covid:a6f3415e7a9286882435641655b8417634290b8a#body_text
is schema:about of	named entity 'scientific' named entity '2019' named entity 'FDA' named entity 'scope' named entity 'virus' named entity 'species' named entity 'cure' named entity 'seventh' named entity 'infect' named entity 'virus' named entity 'virus' named entity 'virus' named entity 'clinical trials' named entity 'vaccines' named entity 'Wuhan' named entity 'clinical trials' named entity 'SARS-CoV-2' named entity 'significant difference' named entity 'influenza viruses' named entity 'self-medication' named entity 'Chloroquine phosphate' named entity 'uncoating' named entity 'enzyme' named entity 'placebo' named entity 'fusion inhibitor' named entity 'lung' named entity 'ACE' named entity 'Covid' named entity 'decapeptide' named entity 'ritonavir' named entity 'ACE' named entity 'remdesivir' named entity 'proteolytic cleavage' named entity 'virus' named entity 'RNA' named entity 'ACE2' named entity 'cell culture' named entity 'remdesivir' named entity 'invasive ventilation' named entity 'ACE2' named entity 'virus' named entity 'host cell' named entity 'WHO' named entity 'viral infection' named entity 'ritonavir' named entity 'neuraminidase inhibitor' named entity 'SARS-CoV-2' named entity 'invasive ventilation' named entity 'hormone' named entity 'viruses' named entity '22nd March' named entity 'respiratory droplets' named entity 'critical care' named entity 'Remdesivir' named entity '28 days' named entity 'SARS-CoV-2 virus' named entity 'ACE2' named entity 'mortality rate' named entity 'ACE2' named entity 'viral replication' named entity 'infection' named entity 'heart failure' named entity 'viral particle' named entity 'angiotensinogen' named entity 'octapeptide' named entity 'ACE' named entity 'liver damage' named entity 'critically ill patients' named entity 'proteases' named entity 'protease inhibitor' named entity 'interact with other drugs' named entity 'hydrolyses' named entity 'virus' named entity 'angiotensin-converting enzyme'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software